RenovoRx (RNXT) Receivables (2024 - 2026)
RenovoRx (RNXT) posted Receivables of $280000.0 for Q1 2026, up 101.44% sequentially from $139000.0 in Q4 2025, and up 15.7% YoY from $242000.0 in Q1 2025.
RenovoRx (RNXT) Receivables (2024 - 2026) Analysis & Trends
RenovoRx has reported Receivables for 3 years, with the latest figure at $280000.0 in Q1 2026.
- Quarterly Receivables rose 15.7% year-over-year to $280000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280000.0 (up 15.7% YoY) and the FY2025 annual result came in at $139000.0, up 223.26% from the prior year.
- Receivables grew to $280000.0 in Q1 2026 per RNXT's latest filing, from $139000.0 in the prior quarter.
- Over five years, Receivables peaked at $363000.0 in Q2 2025 and troughed at $43000.0 in Q4 2024.
- A 3-year average of $206000.0 and a median of $205500.0 in 2025 frame the typical range for Receivables.
- The sharpest annual moves came in 2025 and 2026: Receivables jumped 223.26% in 2025, then gained 15.7% in 2026.
- Over 3 years, Receivables stood at $43000.0 in 2024, then surged by 223.26% to $139000.0 in 2025, then soared by 101.44% to $280000.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $280000.0, $139000.0, and $169000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | - |
| 10 | RenovoRx | 61.72 Mn | 61.72 Mn | 766,000.00 | 480,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 480,000.00 |
| Mar 31, 2026 | 280,000.00 |
| Dec 31, 2025 | 139,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Jun 30, 2025 | 363,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 43,000.00 |